Cutia Therapeutics carries a market capitalization of 1.02B, placing it among publicly traded companies globally.
| Market Cap | 1.02B |
| Enterprise Value | N/A |
Cutia Therapeutics's stock has declined approximately -67.58939% over the past 52 weeks. The 50-day moving average sits at 3.81, while the 200-day moving average is 5.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -67.58939% |
| 50-Day Moving Average | 3.81 |
| 200-Day Moving Average | 5.40 |
| Average Volume (20 Days) | N/A |